Mogo Moringa LLC Announces Voluntary Recall of Select Lots of Moringa Capsules Due to Possible Salmonella Contamination.
Saint Louis, MO — May 25, 2026 — Mogo Moringa LLC, based in Saint Louis, Missouri, is voluntarily recalling specific lots of its Mogo Moringa Capsules after discussions with the U.S. Food and Drug Administration (FDA) regarding a possible Salmonella contamination concern. This voluntary action reflects the company’s commitment to transparency, cooperation, and maintaining high product quality standards.
The product is packaged in a white plastic bottle and sold online through authorized channels. Mogo Moringa LLC does not authorize any third‑party sellers to distribute its products, and customers are encouraged to purchase only from official sources.
Independent third‑party laboratory testing was conducted on retained samples from the affected lots, and no Salmonella was detected. The company is proceeding with this voluntary recall as a precaution and in coordination with the FDA while the agency continues its evaluation.
The recall applies only to the specific lots listed below:
Affected Lots: • Lot 15525AA – Exp 06/2027 • Lot 00926AA – Exp 01/2028
No other lots or Mogo Moringa LLC products are included in this recall.
Consumers who have product from the affected lots are recommended not to use the product